嘌呤能系统在双相情感障碍治疗中的应用：尿酸水平作为躁狂症的筛查指标 - Suppr

Suppr

超能文献

Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

作者信息

Machado-Vieira Rodrigo

出版信息

J Clin Psychopharmacol. 2012 Oct;32(5):735-6. doi: 10.1097/JCP.0b013e318268391d.

DOI:10.1097/JCP.0b013e318268391d

PMID:22926622

Abstract

摘要

相似文献

Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

J Clin Psychopharmacol. 2012 Oct;32(5):735-6. doi: 10.1097/JCP.0b013e318268391d.

Purinergic dysfunction in mania: an integrative model.

Med Hypotheses. 2002 Apr;58(4):297-304. doi: 10.1054/mehy.2001.1543.

Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials.

Br J Psychiatry. 2017 Jan;210(1):10-15. doi: 10.1192/bjp.bp.115.180281. Epub 2016 Nov 17.

Bipolar disorder.

N Engl J Med. 2004 Jul 29;351(5):476-86. doi: 10.1056/NEJMra035354.

Mania matters!

Acta Psychiatr Scand Suppl. 2007(434):1-2. doi: 10.1111/j.1600-0447.2007.01053.x.

Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: Data from a case control study.

Asian J Psychiatr. 2018 Jun;35:15-17. doi: 10.1016/j.ajp.2018.04.030. Epub 2018 Apr 26.

Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence.

Neuropharmacology. 2023 Dec 15;241:109756. doi: 10.1016/j.neuropharm.2023.109756. Epub 2023 Oct 9.

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):749-62.e39. doi: 10.1016/j.jaac.2011.05.011. Epub 2011 Jul 13.

Emerging drugs for bipolar disorder.

Expert Opin Emerg Drugs. 2010 Sep;15(3):453-66. doi: 10.1517/14728214.2010.492393.

Divalproex in the treatment of bipolar disorder.

Psychopharmacol Bull. 2003;37 Suppl 2:67-73.

引用本文的文献

Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response.

Cureus. 2024 Aug 13;16(8):e66784. doi: 10.7759/cureus.66784. eCollection 2024 Aug.

Neuroprotective effects of dimethyl fumarate against manic-like behavior induced by ketamine in rats.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3007-3016. doi: 10.1007/s00210-023-02505-6. Epub 2023 Apr 27.

The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Front Neurosci. 2022 Sep 16;16:998747. doi: 10.3389/fnins.2022.998747. eCollection 2022.

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

CNS Drugs. 2022 Aug;36(8):787-801. doi: 10.1007/s40263-022-00934-0. Epub 2022 Jul 13.

Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Sci Rep. 2021 Sep 15;11(1):18307. doi: 10.1038/s41598-021-97955-4.

State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders.

Life (Basel). 2020 Jun 6;10(6):82. doi: 10.3390/life10060082.

Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Front Psychiatry. 2019 Oct 31;10:767. doi: 10.3389/fpsyt.2019.00767. eCollection 2019.

P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.

Mol Neurobiol. 2020 Mar;57(3):1347-1360. doi: 10.1007/s12035-019-01817-0. Epub 2019 Nov 15.

Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Front Psychiatry. 2018 Aug 21;9:381. doi: 10.3389/fpsyt.2018.00381. eCollection 2018.

Purinergic system in psychiatric diseases.

Mol Psychiatry. 2018 Jan;23(1):94-106. doi: 10.1038/mp.2017.188. Epub 2017 Sep 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

J Clin Psychopharmacol. 2012 Oct;32(5):735-6. doi: 10.1097/JCP.0b013e318268391d.

Purinergic dysfunction in mania: an integrative model.

Med Hypotheses. 2002 Apr;58(4):297-304. doi: 10.1054/mehy.2001.1543.

Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials.

Br J Psychiatry. 2017 Jan;210(1):10-15. doi: 10.1192/bjp.bp.115.180281. Epub 2016 Nov 17.

Bipolar disorder.

N Engl J Med. 2004 Jul 29;351(5):476-86. doi: 10.1056/NEJMra035354.

Mania matters!

Acta Psychiatr Scand Suppl. 2007(434):1-2. doi: 10.1111/j.1600-0447.2007.01053.x.

Serum uric acid levels in first episode mania, effect on clinical presentation and treatment response: Data from a case control study.

Asian J Psychiatr. 2018 Jun;35:15-17. doi: 10.1016/j.ajp.2018.04.030. Epub 2018 Apr 26.

Bipolar mania and epilepsy pathophysiology and treatment may converge in purine metabolism: A new perspective on available evidence.

Neuropharmacology. 2023 Dec 15;241:109756. doi: 10.1016/j.neuropharm.2023.109756. Epub 2023 Oct 9.

Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.

J Am Acad Child Adolesc Psychiatry. 2011 Aug;50(8):749-62.e39. doi: 10.1016/j.jaac.2011.05.011. Epub 2011 Jul 13.

Emerging drugs for bipolar disorder.

Expert Opin Emerg Drugs. 2010 Sep;15(3):453-66. doi: 10.1517/14728214.2010.492393.

Divalproex in the treatment of bipolar disorder.

Psychopharmacol Bull. 2003;37 Suppl 2:67-73.

引用本文的文献

Uric Acid as a Biomarker for Mood Disorders: A Comparative Study of Blood Uric Acid Levels Correlating With the Symptom Severity and Treatment Response.

Cureus. 2024 Aug 13;16(8):e66784. doi: 10.7759/cureus.66784. eCollection 2024 Aug.

Neuroprotective effects of dimethyl fumarate against manic-like behavior induced by ketamine in rats.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3007-3016. doi: 10.1007/s00210-023-02505-6. Epub 2023 Apr 27.

The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Front Neurosci. 2022 Sep 16;16:998747. doi: 10.3389/fnins.2022.998747. eCollection 2022.

The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

CNS Drugs. 2022 Aug;36(8):787-801. doi: 10.1007/s40263-022-00934-0. Epub 2022 Jul 13.

Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Sci Rep. 2021 Sep 15;11(1):18307. doi: 10.1038/s41598-021-97955-4.

State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders.

Life (Basel). 2020 Jun 6;10(6):82. doi: 10.3390/life10060082.

Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Front Psychiatry. 2019 Oct 31;10:767. doi: 10.3389/fpsyt.2019.00767. eCollection 2019.

P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.

Mol Neurobiol. 2020 Mar;57(3):1347-1360. doi: 10.1007/s12035-019-01817-0. Epub 2019 Nov 15.

Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Front Psychiatry. 2018 Aug 21;9:381. doi: 10.3389/fpsyt.2018.00381. eCollection 2018.

Purinergic system in psychiatric diseases.

Mol Psychiatry. 2018 Jan;23(1):94-106. doi: 10.1038/mp.2017.188. Epub 2017 Sep 26.